Non-invasive prenatal testing using cell-free fetal DNA in maternal circulation

Clinica Chimica Acta

Volumn 428, Issue , 2014, Pages 44-50

  Liao, Gary J W ^a   Gronowski, Ann M ^b   Zhao, Zhen ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cell free fetal DNA; Fetal chromosomal aneuploidy; Fetal sex assessment; Non invasive prenatal testing; RhD genotyping; Single gene disorders

Indexed keywords

DNA;

ANEUPLOIDY; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DNA FINGERPRINTING; DNA SEQUENCE; FETUS; GENOME ANALYSIS; GESTATIONAL AGE; HUMAN; MATERNAL BLOOD; MONOGENIC DISORDER; NON INVASIVE MEASUREMENT; NON INVASIVE PRENATAL TESTING; PLACENTAL TRANSFER; PLASMA CELL; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEX DETERMINATION; BLOOD; CYTOLOGY; FEMALE; FETOMATERNAL TRANSFUSION; GENETICS; METABOLISM; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

DNA; FEMALE; FETUS; HUMANS; MATERNAL-FETAL EXCHANGE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84888067933     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.10.007     Document Type: Review

References (77)

1. Malone F.D., Canick J.A., Ball R.H., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005, 353:2001-2011.
2. Mujezinovic F., Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007, 110:687-694.
3. Lo Y.M.D., Corbetta N., Chamberlain P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
4. Wataganara T., Bianchi D.W. Fetal cell-free nucleic acids in the maternal circulation: new clinical applications. Ann N Y Acad Sci 2004, 1022:90-99.
5. Guibert J., Benachi A., Grebille A.G., Ernault P., Zorn J.R., Costa J.M. Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique. Hum Reprod 2003, 18:1733-1736.
6. Alberry M., Maddocks D., Jones M., et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007, 27:415-418.
7. Chim S.S.C., Tong Y.K., Chiu R.W.K., et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 2005, 102:14753-14758.
8. Masuzaki H., Miura K., Yoshiura K., Yoshimura S., Niikawa N., Ishimaru T. Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism. J Med Genet 2004, 41:289-292.
9. Lui Y.N.Y.N., Chik K.W., Chiu R.W.K., Ho C.Y., Lam C.W.K., Lo Y.M.D. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 2002, 48:421-427.
10. Chan K.C.A., Zhang J., Hui A.B.Y., et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004, 50:88-92.
11. Lo Y.M.D., Chan K.C.A., Sun H., et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010, 2.
12. Lo Y.M., Tein M.S., Lau T.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998, 62:768-775.
13. Chiu R.W., Akolekar R., Zheng Y.W., et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011, 342:c7401.
14. Yu S.C., Lee S.W., Jiang P., et al. High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing. Clin Chem 2013, 59:1228-1237.
15. Devaney S.A., Palomaki G.E., Scott J.A., Bianchi D.W. Noninvasive fetal sex determination using cell-free fetal DNA a systematic review and meta-analysis. JAMA 2011, 306:627-636.
16. Macher H.C., Noguerol P., Medrano-Campillo P., et al. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving. Clin Chim Acta 2012, 413:490-494.
17. Wikman A.T., Tiblad E., Karlsson A., Olsson M.L., Westgren M., Reilly M. Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol 2012, 120:227-234.
18. Odeh M., Grinin V., Kais M., Ophir E., Bornstein J. Sonographic fetal sex determination. Obstet Gynecol Surv 2009, 64:50-57.
19. Nimkarn S., New M.I. Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Mol Cell Endocrinol 2009, 300:192-196.
20. Hill M., Finning K., Martin P., et al. Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 2011, 80:68-75.
21. Hill M., Lewis C., Jenkins L., Allen S., Elles R.G., Chitty L.S. Implementing noninvasive prenatal fetal sex determination using cell-free fetal DNA in the United Kingdom. Expert Opin Biol Ther 2012, 12:S119-S126.
22. Moise K.J. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2008, 112:164-176.
23. NICE Routine antenatal anti-D prophylaxis for women who are rhesus D negative: review of NICE technology appraisal guidance 41 2011, London.
24. Lo Y.M.D., Hjelm N.M., Fidler C., et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998, 339:1734-1738.
25. Faas B.H.W., Beuling E.A., Christiaens G.C.M.L., von dem Borne A.E.G.K., van der Schoot C.E. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 1998, 352:1196.
26. Legler T.J., Muller S.P., Haverkamp A., Grill S., Hahn S. Prenatal RhD testing: a review of studies published from 2006 to 2008. Transfus Med Hemother 2009, 36:189-198.
27. Fernandez-Martinez F.J., Galindo A., Garcia-Burguillo A., et al. Noninvasive fetal sex determination in maternal plasma: a prospective feasibility study. Genet Med 2012, 14:101-106.
28. Finning K., Martin P., Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 2004, 1022:119-123.
29. Wagner J., Dzijan S., Marjanovic D., Lauc G. Non-invasive prenatal paternity testing from maternal blood. Int J Legal Med 2009, 123:75-79.
30. Guo X., Bayliss P., Damewood M., et al. A noninvasive test to determine paternity in pregnancy. N Engl J Med 2012, 366:1743-1745.
31. Jiang P.Y., Chan K.C.A., Liao G.J.W., et al. FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma. Bioinformatics 2012, 28:2883-2890.
32. Qu J.Z.Z., Leung T.Y., Jiang P.Y., et al. Noninvasive prenatal determination of twin zygosity by maternal plasma DNA analysis. Clin Chem 2013, 59:427-435.
33. Poon L.L., Leung T.N., Lau T.K., Chow K.C., Lo Y.M. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem 2002, 48:35-41.
34. Chim C.S., Wong A.S., Kwong Y.L. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias. Am J Hematol 2005, 80:282-287.
35. Tong Y.K., Lo Y.M. Plasma epigenetic markers for cancer detection and prenatal diagnosis. Front Biosci 2006, 11:2647-2656.
36. Papageorgiou E.A., Karagrigoriou A., Tsaliki E., Velissariou V., Carter N.P., Patsalis P.C. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med 2011, 17:510-513.
37. Lim J.H., Kim S.Y., Park S.Y., et al. Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma. PLoS One 2011, 6:e27709.
38. Lo Y.M., Tsui N.B., Chiu R.W., et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007, 13:218-223.
39. Fan H.C., Quake S.R. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem 2007, 79:7576-7579.
40. Lo Y.M.D., Lun F.M.F., Chan K.C.A., et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 2007, 104:13116-13121.
41. Chiu R.W., Chan K.C., Gao Y., et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008, 105:20458-20463.
42. Fan H.C., Blumenfeld Y.J., Chitkara U., Hudgins L., Quake S.R. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008, 105:16266-16271.
43. Sparks A.B., Wang E.T., Struble C.A., et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenatl Diagn 2012, 32:3-9.
44. Lo Y.M., Chiu R.W. Genomic analysis of fetal nucleic acids in maternal blood. Annu Rev Genomics Hum Genet 2012, 13:285-306.
45. Chen E.Z., Chiu R.W., Sun H., et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011, 6:e21791.
46. Palomaki G.E., Kloza E.M., Lambert-Messerlian G.M., et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011, 13:913-920.
47. Lau T.K., Chan M.K., Lo P.S., et al. Clinical utility of noninvasive fetal trisomy (NIFTY) test-early experience. J Matern Fetal Neonatal Med 2012, 25:1856-1859.
48. Nicolaides K.H., Syngelaki A., Ashoor G., Birdir C., Touzet G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012, 207. [374 e371-376].
49. Fairbrother G., Johnson S., Musci T.J., Song K. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population. Prenat Diagn 2013, 33:580-583.
50. Dan S., Wang W., Ren J., et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn 2012, 32:1225-1232.
51. Futch T., Spinosa J., Bhatt S., de Feo E., Rava R.P., Sehnert A.J. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013, 33:569-574.
52. Chen E.Z., Chiu R.W.K., Sun H., et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011, 6.
53. Fan H.C., Gu W., Wang J.B., Blumenfeld Y.J., El-Sayed Y.Y., Quake S.R. Non-invasive prenatal measurement of the fetal genome. Nature 2012, 487:320-+.
54. Kitzman J.O., Snyder M.W., Ventura M., et al. Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 2012, 4.
55. Chen S., Ge H., Wang X., et al. Haplotype-assisted accurate noninvasive fetal whole genome recovery through maternal plasma sequencing. Genome Med 2013, 5:18.
56. WHO Genes and human disease http://www.who.int/genomics/public/geneticdiseases/.
57. Gonzalez-Gonzalez M.C., Trujillo M.J., de Alba M.R., et al. Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Diagn 2003, 23:232-234.
58. Gonzalez-Gonzalez M.C., Trujillo M.J., De alba M.R., Ramos C. Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR. Neurology 2003, 60:1214-1215.
59. Bustamante-Aragones A., Trujillo-Tiebas M.J., Gallego-Merlo J., et al. Prenatal diagnosis of Huntington disease in maternal plasma: direct and indirect study. Eur J Neurol 2008, 15:1338-1344.
60. Amicucci P., Gennarelli M., Novelli G., Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000, 46:301-302.
61. Saito H., Sekizawa A., Morimoto T., Suzuki M., Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000, 356:1170.
62. Li Y., Page-Christiaens G.C.M.L., Gille J.J.P., Holzgreve W., Hahn S. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn 2007, 27:11-17.
63. Lun F.M.F., Tsui N.B.Y., Chan K.C.A., et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci USA 2008, 105:19920-19925.
64. Barrett A.N., McDonnell T.C.R., Chan K.C.A., Chitty L.S. Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clin Chem 2012, 58:1026-1032.
65. Tsui N.B.Y., Kadir R.A., Chan K.C.A., et al. Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 2011, 117:3684-3691.
66. Lam K.W.G., Jiang P., Liao G.J.W., et al. Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to beta-thalassemia. Clin Chem 2012, 58:1467-1475.
67. Chiu R.W.K., Lau T.K., Cheung P.T., Gong Z.Q., Leung T.N., Lo Y.M.D. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 2002, 48:778-780.
68. Ehrich M., Deciu C., Zwiefelhofer T., et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011, 204. [205 e201-211].
69. Bianchi D.W., Platt L.D., Goldberg J.D., Abuhamad A.Z., Sehnert A.J., Rava R.P. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012, 119:890-901.
70. Ashoor G., Syngelaki A., Wagner M., Birdir C., Nicolaides K.H. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012, 206. [322 e321-325].
71. Jiang F., Ren J., Chen F., et al. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics 2012, 5:57.
72. Lau T.K., Chen F., Pan X., et al. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. J Matern Fetal Neonatal Med 2012, 25:1370-1374.
73. Norton M.E., Brar H., Weiss J., et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012, 207. [137 e131-138].
74. Palomaki G.E., Deciu C., Kloza E.M., et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012, 14:296-305.
75. Sparks A.B., Struble C.A., Wang E.T., Song K., Oliphant A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012, 206. [319 e311-319].
76. Liang D., Lv W., Wang H., et al. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenat Diagn 2013, 33:409-415.
77. Nicolaides K.H., Syngelaki A., Gil M., Atanasova V., Markova D. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn 2013, 33:575-579.